Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2024 (2)
  • 2023 (4)
  • 2022 (6)
  • 2021 (1)
  • 2018 (1)

Subject

  • Drug Trafficking (91)
  • Guilty Plea (38)
  • Guns/Weapons (38)
  • Arrests/Convictions - Major (34)
  • Fake Pills (29)
  • HIDTA (29)
  • Synthetic drugs (27)
  • Gangs (24)
  • Take Back Day (24)
  • Prescription Drugs (23)
  • Seizures (Drugs/Property) (23)
  • Diversion Division (21)
  • OCDETF/Task Force (18)
  • Task Forces/Task Force Officers (18)
  • Fentanyl Awareness (15)
  • Outreach/Drug Prevention (15)
  • Major Law Enforcement Operation (13)
  • One Pill Can Kill (13)
  • Money Laundering (12)
  • Press Conferences (10)
  • Prevention/Education - DEA websites GSAD, JTT etc (6)
  • International/Foreign Operations (4)
  • Public and Media Affairs - also see Congressional Affairs (4)
  • Fentanyl Free America (3)
  • Counterfeit Pills (2)
  • Dark Web- Internet Trafficking (2)
  • Extraditions (2)
  • Overdose (2)
  • Asset Forfeiture (1)
  • Campaigns (1)
  • Cartel (1)
  • Intelligence Division - Intelligence Products (1)
  • Intergovernmental Affairs (1)
  • Terrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (15)

Drug Name

  • Oxycodone (2)
  • Methamphetamine (1)

Field Division

  • Atlanta (12)
  • Chicago (19)
  • Dallas (8)
  • El Paso (11)
  • Houston (7)
  • Los Angeles (4)
  • Louisville (7)
  • Miami (16)
  • New England (5)
  • New Jersey (11)
  • New Orleans (4)
  • New York (21)
  • Omaha (3)
  • Philadelphia (1)
  • Phoenix (2)
  • Rocky Mountain (4)
  • San Diego (5)
  • San Francisco (8)
  • Seattle (9)
  • Sede (10)
  • St. Louis (36)
  • Washington, DC (35)
Clear All Results
15 Results - Showing 1 to 10
PRESS RELEASE

DEA Rocky Mountain Field Division Drug Take Back Totals

CENTENNIAL, CO – The Drug Enforcement Administration's Rocky Mountain Field Division (RMFD) has final totals following the most recent drug Take Back Day April 25, 2026. Across the Division's four states (Colorado, Utah, Montana, Wyoming) 157 law enforcement departments at 225 collection sites collected 27,590 pounds of unneeded, unwanted, and...
PRESS RELEASE

DEA Rocky Mountain Field Division Encourages Prescription Take Back This Saturday

The Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) is proud to be part of the 26th annual National Prescription Drug Take Back Day this Saturday, April 27, 2024 from 10:00am to 2:00pm MST at dozens of locations across Colorado, Utah, Wyoming and Montana. “DEA’s Take Back events serve as...
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
PRESS RELEASE

Passaic County Doctor Charged in Conspiracy to Distribute Opioids

NEWARK, N.J. – A Passaic County, New Jersey, doctor was charged with conspiring to distribute opioids without a legitimate medical reason, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Field Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced. Lisa Ferraro, 65, of Hillsdale, New...
PRESS RELEASE

Toms River Woman Charged with Unauthorized Practice of Medicine, Forgery, Health Care Claims Fraud, and Distribution of a Controlled Dangerous Substance

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division Cheryl Ortiz and Ocean County Prosecutor Bradley D. Billhimer announced that on July 25, 2023, Maria F. Macburnie, aka Marife L. Macburnie, 62, of Toms River, was charged with Practicing Medicine by an Unlicensed...
PRESS RELEASE

Greenwood Village Psychiatrist Sentenced to Prison for Illegal Distribution of Controlled Substances and Financial Crimes

DENVER – Howard Weiss of Greenwood Village was sentenced to six months in federal prison for distributing a controlled substance outside the usual course of professional practice, for structuring financial transactions in a way to evade reporting requirements, and for engaging in monetary transactions greater than $10,000 that were derived...
PRESS RELEASE

Former Office Manager of New Jersey Medical Practice Admits Conspiring with Doctor to Divert Controlled Substances

NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former office manager of a New Jersey medical practice admitted conspiring with the doctor who owned the...
PRESS RELEASE

Department of Justice Files Nationwide Lawsuit Against Amerisource Bergen Corp. and Subsidiaries for Controlled Substances Act Violations

NEWARK, N.J. – In a civil complaint filed today, the Department of Justice alleges that AmerisourceBergen Corp. and two of its subsidiaries, AmerisourceBergen Drug Corp. and Integrated Commercialization Solutions LLC (AmerisourceBergen), collectively one of the country’s largest wholesale pharmaceutical distributors and one of the largest companies in America by revenue...
PRESS RELEASE

New Jersey Pharmacy Admits Illegal Distribution of Prescription Opioids and Kickback Scheme

NEWARK, N.J. – Susan A. Gibson, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, Scott J. Lampert, Special Agent in Charge of the U.S. Department of Health and Human Services, Office of Inspector General, Office of Investigations-New Jersey Field Office, Patrick J. Hegarty, Defense Criminal Investigative...
PRESS RELEASE

Pharmacist Admits Filling Counterfeit Prescriptions Selling Oxycodone and Codeine in Exchange for Cash

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a pharmacist and pharmacy owner pleaded guilty today to violating the Controlled Substances Act by filling fraudulent and counterfeit...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster